ERBB2 and gastric cancer: Although, due to a lack of survival data of the cohort, our research cannot take a position on the former issue, we provide a valuable information on the prevalence of HER2 overexpression in the group of 104 GC patients of Polish origin, making the assessment according to the updated guidelines for HER2 testing in this disease entity.